Table 1 Reports of pancreatic resection for metastatic ocular malignant melanoma
Author | Gender | Age | Interval (year) | Diagnosis | Tumor size (cm) | Operative method | Additional treatment | Follow-up period (month) | Prognosis |
|---|---|---|---|---|---|---|---|---|---|
Johansson et al. (1970) [21] | F | 79 | 12 | NA | NA | PD | None | 11 | Alive w/o rec Alive without recurrence |
Camp et al. (2002) [22] | F | 62 | 6 | CT | 5 | DP + S | None | 20 | Alive without recurrence |
Nifkarjam et al. (2003) [23] | F | 45 | 12 | CT MRI PET-CT | 3 | PPPD | None | 6 | Alive without recurrence |
M | 55 | 13 | CT PET-CT | NA | TP | None | 7 | Alive without recurrence | |
Vagefi et al. (2010) [19] | F | 57 | 28 | CT MRI PET-CT | 2.2 | DP + S | None | NA | NA |
He et al. (2010) [20] | M | 39 | 5 | CT MRI | 18 | DP + S | Adjuvant chemotherapy | 25 | Alive without recurrence |
De Maura et al. (2016)[24] | F | 58 | NA | CT EUS–FNA | 4 | PD | Adjuvant chemotherapy | NA | Alive without recurrence |
Our case | F | 48 | 5 | CT EUS PET-CT | 2.7 | DP + S | Adjuvant chemotherapy | 40 | Alive with the recurrence |